Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02533-18
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2019
Authors
Publisher
American Society for Microbiology